Assembly Biosciences (ASMB) EBT Margin (2017 - 2026)
Assembly Biosciences' (ASMB) quarterly EBT Margin came in at 142.42% in Q1 2026, down 3643.0% year-on-year from 4.02% in Q1 2025, and down 373.81% quarter-over-quarter from 52.01% in Q4 2025.
Assembly Biosciences (ASMB) EBT Margin (2017 - 2026) Analysis & Trends
Assembly Biosciences' EBT Margin history runs 9 years deep, the most recent figure standing at 142.42% for Q1 2026.
- On a quarterly basis, EBT Margin fell 3643.0% year-over-year to 142.42% in Q1 2026; TTM through Mar 2026 was 12.66%, a 11408.0% increase from a year earlier, with the FY2025 full-year figure at 8.47%, up 13125.0% from the prior year.
- EBT Margin slipped to 142.42% in Q1 2026 per ASMB's latest filing, from 52.01% in the prior quarter.
- Across five years, EBT Margin topped out at 52.01% in Q4 2025 and bottomed at 156.91% in Q1 2024.
- The 4-year median for EBT Margin is 133.19% (2024), against an average of 110.49%.
- Across the five-year window, EBT Margin soared 19353 bps in 2025 and slumped 3643 bps in 2026, its largest moves.
- Year by year, EBT Margin stood at 152.58% in 2023, then grew by 7 bps to 141.51% in 2024, then soared by 137 bps to 52.01% in 2025, then slumped by 374 bps to 142.42% in 2026.
- Per Business Quant, the three latest ASMB EBT Margin figures stand at 142.42% (Q1 2026), 52.01% (Q4 2025), and 85.23% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 17.13% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 33.74% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Assembly Biosciences | 431.63 Mn | 205.03 Mn | - | -142.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -142.42% |
| Dec 31, 2025 | 52.01% |
| Sep 30, 2025 | -85.23% |
| Jun 30, 2025 | -105.94% |
| Mar 31, 2025 | -105.99% |
| Dec 31, 2024 | -141.51% |
| Sep 30, 2024 | -140.44% |
| Jun 30, 2024 | -125.93% |
| Mar 31, 2024 | -156.91% |
| Dec 31, 2023 | -152.58% |
| Sep 30, 2021 | -431.15% |
| Dec 31, 2020 | -3,801.16% |
| Sep 30, 2020 | -9.68% |
| Jun 30, 2020 | 18.46% |
| Mar 31, 2020 | -653.15% |
| Dec 31, 2019 | -583.70% |
| Sep 30, 2019 | -591.11% |
| Jun 30, 2019 | -601.10% |
| Mar 31, 2019 | -696.50% |
| Dec 31, 2018 | -669.93% |